Anti-Cancer Effect of Moroccan Cobra Naja haje Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell Culture
Open Access
- 4 June 2021
- Vol. 13 (6), 402
- https://doi.org/10.3390/toxins13060402
Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver cancer in adults, the fifth most common malignancy worldwide and the third leading cause of cancer related death. An alternative to the surgical treatments and drugs, such as sorafenib, commonly used in medicine is necessary to overcome this public health problem. In this study, we determine the anticancer effect on HCC of Moroccan cobra Naja haje venom and its fraction obtained by gel filtration chromatography against Huh7.5 cancer cell line. Cells were grown together with WI38 human fibroblast cells, LX2 human hepatic stellate cell line, and human endothelial cells (HUVEC) in MCTS (multi-cellular tumor spheroids) models. The hepatotoxicity of venom and its fractions were also evaluated using the normal hepatocytes cell line (Fa2N-4 cells). Our results showed that an anti HCC activity of Moroccan cobra Naja haje venom and, more specifically, the F7 fraction of gel filtration chromatography exhibited the greatest anti-hepatocellular carcinoma effect by decreasing the size of MCTS. This effect is associated with a low toxicity against normal hepatocytes. These results strongly suggest that the F7 fraction of Moroccan cobra Naja haje venom obtained by gel filtration chromatography possesses the ability to inhibit cancer cells proliferation. More research is needed to identify the specific molecule(s) responsible for the anticancer effect and investigate their mechanism of action.Keywords
Funding Information
- Institut Pasteur Korea (2017M3A9G7072864 and NRF-2017M3A9G6068246)
This publication has 43 references indexed in Scilit:
- Therapeutic potential of snake venom in cancer therapy: current perspectivesAsian Pacific Journal of Tropical Biomedicine, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapiesInternational Journal of Clinical Practice, 2011
- Molecular approaches to treatment of hepatocellular carcinomaDigestive and Liver Disease, 2010
- Hepatocellular carcinoma: a global viewNature Reviews Gastroenterology & Hepatology, 2010
- Expression, purification and characterization of recombinant Jerdonitin, a P-II class snake venom metalloproteinase comprising metalloproteinase and disintegrin domainsToxicon, 2010
- Voltage-gated potassium channels as therapeutic targetsNature Reviews Drug Discovery, 2009
- Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damageBiochemical Journal, 2005
- Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cellsLaboratory Investigation, 2004
- Chlorotoxin Inhibits Glioma Cell Invasion via Matrix Metalloproteinase-2Online Journal of Public Health Informatics, 2003